1. |
Alshekhlee A, Miles JD, Katirji B, et al. Incidence and mortality rates of myasthenia gr-avis and myasthenic crisis in US hospitals. Neurology, 2009, 72(18):1548-1554.
|
2. |
Richman DP, Agius MA. Treatment of autoimmune myasthenia gravis. Neurology, 2012, 61(12):1652-1661.
|
3. |
Gritti P, Sgarzi M, Carrara B, et al. A standardized protocol for the perioperative management of myasthenia gravis patients. Experience with 110 patients. Acta Anaesthesiol Scand, 2012, 56(1):66-75.
|
4. |
Wendell LC, Levine JM. Myasthenic crisis. Neurohospitalist, 2011, 1(1):16-22.
|
5. |
Phillips LH. The epidemiology of myasthenia gravis. Semin Neurol, 2004, 24(1):17-20.
|
6. |
Lee HS, Lee HE, Bae MK, et al. Predictive factors for myasthenic crisis after videosco-pic thymectomy in patients with myasthenia gravis. Muscle Nerve, 2015, 52(2):216-220.
|
7. |
刘晓青, 桑岭, 陈思蓓, 等. 重症肌无力患者胸腺切除术后危象的分析. 广东医学, 2014, 35(23):3667-3669.
|
8. |
Leuzzi G, Meacci E, Cusumano G, Cesario A, Chiappetta M, et al. Thymectomy in my-asthenia gravis:proposal for a predictive score of postoperative myasthenic crisis. Eur J Cardiothorac Surg, 2014, 45(4):76-88.
|
9. |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the qu-ality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9):603-605.
|
10. |
Watanabe A, Watanabe T, Obama T, et al. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg, 2004, 127(3):868-876.
|
11. |
Nam TS, Lee SH, Kim BC, et al. Clinical characteristics and predictive factors of myasthenic crisis after thymectomy. J Clin Neurosci, 2011, 18(9):1185-1188.
|
12. |
Chu XY.Xue ZQ Wang RW, et al. Predictors of postoperative myasthenic crisis in pat-ients with myasthenia gravis after thymectomy. Chin Med J (Engl), 2011, 124(8):1246-1250.
|
13. |
Yu SS,Lin J, Fu XG, et al. Risk factors of myasthenic crisis after thymectomy in 178generalized myasthenia gravis patients in a five-year follow-up study. 中国医药指南, 2015(7):112-112,113.
|
14. |
Choi KH, Nam TS, Lee SH, et al. Preoperative pulmonary function is strongly related to myasthenic crisis after thymectomy. Neurol India, 2014, 62(2):164-168.
|
15. |
Ando T, Omasa M, Kondo T, et al. Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis. Eur J Cardiothorac Surg, 2015, 48(5):705-709.
|
16. |
王志农, 何斌, 徐志云, 等. 重症肌无力行胸腺切除术后危象的防治(附98例分析). 第二军医大学学报, 2003, 24(11):1175-1177.
|
17. |
梁胜景, 林辉, 贺福榜. 重症肌无力胸腺切除术后发生危象的原因及对策. 医学文献, 2005, 24(4):467-469.
|
18. |
王旭广, 杨鲲鹏, 寿化山, 等. 重症肌无力胸腺切除术后发生肌无力危象的危险因素. 中华胸心血管外科杂志, 2006, 22(4):268-269.
|
19. |
刘卫彬, 门丽娜, 唐白云, 等. 全身型重症肌无力患者术后危象的相关因素分析. 中华医学杂志, 2006, 86(39):2737-2740.
|
20. |
陈佶, 庞烈文, 陈志明, 等. 重症肌无力患者胸腺切除术后危象发生的多因素分析. 中国临床神经科学, 2007, 15(2):169-173.
|
21. |
马金山, 王小雷, 陈康, 等. 重症肌无力病人胸腺切除术后危象发生的多因素分析. 中华胸心血管外科杂志, 2011, 27(1):27-29.
|
22. |
牛耀东, 王铁栓, 赵松, 等. 重症肌无力术后早期危象的预测因素. 中华国老年学杂志, 2011, 33(10):2362-2364.
|
23. |
张捷, 李双玲, 王东信等. 重症肌无力伴胸腺瘤患者术后发生肌无力危象的危险因素分析. 实用医学杂志, 2013, 29(10):50-52.
|
24. |
Thomas CE, Mayer SA, Gungor Y, et al. Myasthenic crisis:clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology, 1997, 48(5):1253-1260.
|
25. |
Rabinstein AA, Wijdicks EF. Warning signs of imminent respiratory failure in neurolog-ical patients. Semin Neurol, 2003, 23(1):97-104.
|
26. |
Lacomis D. Myasthenic Crisis. Neurocrit Care, 2005, 3(3):189-194.
|
27. |
Jani-Acsadi A, Lisak RP. Myasthenic crisis:guidelines for prevention and treatment. J Neurol Sci, 2007, 261(1-2):127-133.
|
28. |
Ahmed S, Kirmani JF, Janjua N, et al. An Update on Myasthenic Crisis. Curr Treat Options Neurol, 2005, 7(2):129-141.
|
29. |
Cormier Y, Kashima H, Summer W, et al. Upper airways obstruction with bilateral vocal cord paralysis. Chest, 1979, 75(4):423-427.
|
30. |
Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis:past, present, and future. J Clin Invest, 2006, 116(11):2843-2854.
|
31. |
Aarli JA. Late-onset myasthenia gravis:a changing scene. Arch Neurol, 1999, 56(1):25-27.
|
32. |
Dushay KM, Zibrak JD, Jensen WA. Myasthenia gravis presenting as isolated respiratory failure. Chest, 1990, 97(1):232-234.
|
33. |
Bershad EM, Feen ES, Suarez JI. Myasthenia gravis crisis. South Med J, 2008, 101(1):63-69.
|
34. |
Chevrolet JC, Deleamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barre syndrome. Am Rev Respir Dis, 1991, 144(4):814-818.
|
35. |
Prigent H, Orlikowski D, Letilly N, et al. Vital capacity versus maximal inspiratory pressure in patients with Guillain-Barré syndrome and myastheniagravis. Neurocrit Care, 2012, 17(2):236-239.
|
36. |
Loach AB, Young AC, Spalding JM, et al. Postoperative management after thymectomy. Br Med J, 1975, 1(5953):309-312.
|
37. |
Deymeer F, Gungor-Tuncer O, Yilmaz V, et al. Clinical comparison of anti-MuSK-vsantiAChR-positive and seronegative myasthenia gravis. Neurology, 2007, 68(8):609-611.
|
38. |
Nicolle MW. Myasthenia gravis. Neurologist, 2002, 8(1):2-21.
|
39. |
Aurangzeb S, Tariq M, M, et al. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis. J Pak Med Assoc, 2009, 59(5):289-292.
|
40. |
Kalita J, Kohat AK, Misra UK. Predictors of outcome of myasthenic crisis. Neurol Sci, 2014, 35(7):1109-1114.
|